期刊文献+

胰腺癌细胞株Runx3基因启动子区CpG岛甲基化的检测 被引量:1

Detection of CpG island methylation of Runx3 gene promoter region in pancreatic cancer cell lines
下载PDF
导出
摘要 目的探讨胰腺癌细胞株中Runx3基因启动子区CpG岛的甲基化水平。方法应用甲基化特异性PCR方法检测Panc-1、BxPC-3、AsPC-1三种胰腺癌细胞株及正常胰腺组织RunX3基因启动子区CpG岛甲基化水平。结果在Panc-1、BxPC-3、AsPC-1细胞株中Runx3基因启动子区CpG岛的甲基化引物均发生扩增,非甲基化引物未发生扩增;在正常胰腺组织中Runx3基因启动子区CpG岛的甲基化引物未发生扩增,非甲基化引物发生扩增。结论 Panc-1、BxPC-3、AsPC-1中存在Runx3基因启动子区CpG岛的完全甲基化。 Objective To identify CpG island methylation of Runx3 gene promoter region in pancreatic cancer cell lines. Methods CpG island methylation of Runx3 gene promoter region was determined by methylation-specific PCR in Panc-1, BxPC-3, AsPC-1 cell lines and normal pancreatic tissue. Results The methylated primers of CpG island of Runx3 gene promoter region other than non-methylated primers were amplified in Panc-1, BxPC-3 and AsPC-1 cell lines, while they were just the opposite in normal pancreatic tissue. Conclusion There exists the CpG island methylation of Runx3 gene promoter region in pancreatic cancer cell lines Panc-1, BxPC-3 and AsPC-1.
出处 《广东医学院学报》 2011年第3期248-250,共3页 Journal of Guangdong Medical College
关键词 胰腺癌 RUNX3基因 甲基化 pancreatic cancer Run gent methylation
  • 相关文献

参考文献2

二级参考文献46

  • 1王彬,李槐.胰腺癌的综合治疗[J].中国介入影像与治疗学,2007,4(2):154-158. 被引量:9
  • 2Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005 [J]. CA Cancer J Clin, 2005, 55(1): 10-30.
  • 3Sener SF, Fremgen A, Mcnck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database [J]. J Am Coil Surg, 1999, 189(1): 1-7.
  • 4Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinema [J]. Br J Surg, 2004, 91(5): 586-594.
  • 5Harrison LE, Brennan MF. Portal vein involvement in pancreatic cancer: a sign of unresectability? [J]. Adv Surg, 1997, 31: 375-394.
  • 6Fusai G, Wamaar N, Sabin CA, et al. Outcome of RI resection in patients undergoing pancreatico-duodenectomy for pancreatic cancer[J]. EurJ Surg Oncol, 2008, 34(12): 1309-1315.
  • 7Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial [J ]. Ann Surg, 1999, 230(3): 322-328.
  • 8Russell RC. Palliation of pain and jaundice: an overview[J]. Ann Oncol, 1999, 10(Suppl 4): 165-169.
  • 9Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial [J]. Ann Surg, 1993, 217 (5): 447-455.
  • 10Das A, Sivak MV Jr. Endoscopic palliation for inoperable pancreatic cancer[J]. Cancer Control, 2000, 7(5): 452-457.

共引文献22

同被引文献16

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部